Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI North America CPhI North America
Not Confirmed
Not Confirmed
20-22 May, 2025
Not Confirmed
Not Confirmed
22-25 April, 2025
AACR Annual meetingAACR Annual meeting
Not Confirmed
Not Confirmed
25-30 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
Industry Trade Show
Not Confirmed
22-25 April, 2025
AACR Annual meetingAACR Annual meeting
Industry Trade Show
Not Confirmed
25-30 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/top-pharma-companies-drugs-in-2024-merck-s-keytruda-maintains-top-spot-as-novo-s-semaglutide-nips-at-its-heels
10 Dec 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211663
06 Apr 2023
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216327
08 Mar 2023
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf
23 Sep 2022
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216521
14 Sep 2022
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215675
01 Aug 2022
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212077
Regulatory Info : RX
Registration Country : USA
Dosage Form : SOLUTION/DROPS;OTIC
Brand Name : ACETIC ACID
Dosage Strength : 2%
Packaging :
Approval Date : 2005-02-24
Application Number : 40607
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMLODIPINE BESYLATE
Dosage Strength : EQ 2.5MG BASE
Packaging :
Approval Date : 2007-07-09
Application Number : 77759
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMLODIPINE BESYLATE
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2007-07-09
Application Number : 77759
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMLODIPINE BESYLATE
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2007-07-09
Application Number : 77759
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
Dosage Form : TABLET;ORAL
Brand Name : AMLODIPINE AND OLMESARTAN...
Dosage Strength : EQ 5MG BASE;20MG
Packaging :
Approval Date : 2018-12-03
Application Number : 209010
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
Dosage Form : TABLET;ORAL
Brand Name : AMLODIPINE AND OLMESARTAN...
Dosage Strength : EQ 10MG BASE;20MG
Packaging :
Approval Date : 2018-12-03
Application Number : 209010
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
Dosage Form : TABLET;ORAL
Brand Name : AMLODIPINE AND OLMESARTAN...
Dosage Strength : EQ 5MG BASE;40MG
Packaging :
Approval Date : 2018-12-03
Application Number : 209010
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
Dosage Form : TABLET;ORAL
Brand Name : AMLODIPINE AND OLMESARTAN...
Dosage Strength : EQ 10MG BASE;40MG
Packaging :
Approval Date : 2018-12-03
Application Number : 209010
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : TABLET; ORAL
Brand Name : APIXABAN
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number : 218119
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ARIPIPRAZOLE
Dosage Strength : 2MG
Packaging :
Approval Date : 2016-09-29
Application Number : 206383
Regulatory Info : RX
Registration Country : USA
RLD : No
TE Code : AT
Dosage Form : SOLUTION/DROPS; OTIC
Proprietary Name : ACETIC ACID
Dosage Strength : 2%
Approval Date : 2005-02-24
Application Number : 40607
RX/OTC/DISCN : RX
RLD : No
TE Code : AT
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : AMLODIPINE BESYLATE
Dosage Strength : EQ 2.5MG BASE
Approval Date : 2007-07-09
Application Number : 77759
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : AMLODIPINE BESYLATE
Dosage Strength : EQ 5MG BASE
Approval Date : 2007-07-09
Application Number : 77759
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : AMLODIPINE BESYLATE
Dosage Strength : EQ 10MG BASE
Approval Date : 2007-07-09
Application Number : 77759
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AB
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
Dosage Form : TABLET; ORAL
Proprietary Name : AMLODIPINE AND OLMESARTA...
Dosage Strength : EQ 5MG BASE;20MG
Approval Date : 2018-12-03
Application Number : 209010
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
Dosage Form : TABLET; ORAL
Proprietary Name : AMLODIPINE AND OLMESARTA...
Dosage Strength : EQ 5MG BASE;40MG
Approval Date : 2018-12-03
Application Number : 209010
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
Dosage Form : TABLET; ORAL
Proprietary Name : AMLODIPINE AND OLMESARTA...
Dosage Strength : EQ 10MG BASE;20MG
Approval Date : 2018-12-03
Application Number : 209010
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
Dosage Form : TABLET; ORAL
Proprietary Name : AMLODIPINE AND OLMESARTA...
Dosage Strength : EQ 10MG BASE;40MG
Approval Date : 2018-12-03
Application Number : 209010
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD :
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : APIXABAN
Dosage Strength : 2.5MG
Approval Date :
Application Number : 218119
RX/OTC/DISCN :
RLD :
TE Code :
RLD : No
TE Code : AB
Dosage Form : TABLET, ORALLY DISINTEGRATING;...
Proprietary Name : ARIPIPRAZOLE
Dosage Strength : 10MG
Approval Date : 2018-04-18
Application Number : 207240
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Inspections and registrations
ABOUT THIS PAGE